Therapy of HIV-1 infection

    loading  Checking for direct PDF access through Ovid

Abstract

Many new agents are currently being evaluated in clinical trials to determine their efficacy in treating patients infected with HIV-1. Nucleoside analogs which inhibit HIV reverse-transcriptase continue to be the mainstay of therapy. Recent observations, published during this review period, questioned the most appropriate time to initiate antiretroviral therapy and have forced the re-examination of previous recommendations. This review will address the recent and significant findings for monotherapy, combination therapy and immunotherapy for HIV-1 infection and discuss the trend towards a more individualized therapeutic approach in managing patients infected with HIV-1.

Related Topics

    loading  Loading Related Articles